The Experimental Oncology is an English-language journal that publishes review articles, original contributions, short communications, case reports and technical advances presenting new data in the field of experimental and fundamental oncology. Manuscripts should be written in English, contain original work, which has not been published or submitted for publication elsewhere. It also implies the transfer of the Copyright from the author to “Experimental Oncology”. No part of journal publications may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the prior permission of the publisher.
The procedure of peer review
The peer-review process is based on the policy of confidentiality, equity, and uniformity.
After submission of the paper to the journal, firstly it undergoes Editorial Office Assessment. The Editor-in-Chief checks that the paper is appropriate for the journal in accordance with its topic, is original, and is written in good-quality English. The Editor-in-Chief has the right to decline papers which do not fit the journal profile, contain no new information or which scientific and methodological level is not satisfactory. In such a case, the paper may be rejected without being reviewed any further. If the paper is considered appropriate, it is directed to the Section Editor.
The Section Editor contacts available expert reviewers, and the paper is sent to at least two experts along with a special EO review form. The review of the manuscript, if possible, should be completed within 2 weeks. After completion, the review is then submitted to the journal, with a recommendation of acceptance of the manuscript, acceptance with minor revision, major revision, or rejection. The reviewers are asked to share the policy of confidentiality, objectivity, and avoid conflict of interest.
The Section Editor considers all the returned reviews, and if they differ principally, may invite the third reviewer for additional opinion before making a decision.
The final decision is made by the Deputy Editor based on the opinions of the reviewers and recommendations of the Section Editor. If the revision of the paper is required, the Deputy Editor recommends the reviewer for the resubmitted revised paper.
During the procedure of the reviewing, authors are informed about its details by e-mail. The comments of the reviewers of the EO are anonymous.
Instructions to authors
Manuscripts should be formatted: Times New Roman or Arial font, double spacing. The order of presentation for original contributions and short communications is the following:
Title Page, including title, author(s)’ name(s) and their affiliation, full address of corresponding authors (Tel. No., Fax and E-mail), postal code for other authors, abbreviations listed in alphabetic order, and total number of Figures and Tables. The title page should be on a separate page.
Abstract should contain such sections as Aim; Materials and Methods; Results; Conclusion; Key Words (up to six words). As a rule, the abstract should not contain abbreviations, footnotes, or references.
Materials and Methods, including number of animals, their species, strain, line, ages, sex, weight and breeding, method of euthanasia, information on chemicals, devices and drugs used (manufacturer, country, dose(s) and route(s) of administration). Statistical methods used should be outlined. Authors should mention if they have got Ethical Committee permission for studies if they have worked with human or animal material.
Discussion (may be combined with section “Results”).
Acknowledgements, including the grant identification if financial support has been provided.
References. All references cited in the manuscript should be given in the order of citing. References are identified in the text by Arabic numerals in the square brackets. Each reference should list the author’s last name, followed by all initials, title of paper referred to, abbreviated title of periodicals, year, volume number, and first and last page numbers. If there are more than three authors in a cited paper, only first three authors’ names should be provided, and list should be continued by et al. Authors’ names and volume number should be in Bold. Abbreviations of journal titles should follow those used in Current Contents. This journal should be cited as Exp Oncol.
Merlo A, Gabrielson E, Askin F, et al. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994; 54: 640–2.
Calvin M. Evolution and cancer. In: Huberman E, Barr SH, eds. The role of chemicals and radiation in the etiology of cancer. New York: Raven Press, 1985: 51–63.
Pearsall NN, Weiser RS. The Macrophage. Philadelphia: Lea & Febiger, 1970. 204 p.
Unpublished results and personal communications should be cited in the body of text.
Tables. Each Table must be typed on separate sheet with title above and explanatory notes below the Table, has to be numbered with Arabic numerals, and has to be cited in the text.
Figures. All illustrations should be numbered in order of appearance with consecutive Arabic numerals. The Figures should be submitted as separate files for each figure or part of figure block where:
- graphic figures should be presented in Excel format;
- photographs should be done in tiff or jpg formats with minimal resolution of 300 dpi for 80 mm size for 1 column (half page width) or 165 mm — for 2 columns (full page width).
Legends. The legends of figures should be inserted into the text on a separate page (or in the end of paper).
Nonstandard abbreviation should be defined when used in the text.
The manuscript should be submitted to the Editorial Office in electronic format on E-mail: firstname.lastname@example.org ; email@example.com
Morion LLC, Postal address: 10A Bazhana ave., 02140, Kyiv-140, Ukraine, Phone / Fax:+38 (044) 585-9710 (multi-channel). E-mail: firstname.lastname@example.org
SJR indicator — 0.444 (2017);
H-index — 37.0 (2017).
Index Copernicus — 109.73 (2016)
- Publication schedule: Printed and posted online quarterly
- Average time from submission to initial decision (full-length manuscripts): 1 month (2018)
- Average time from acceptance to print: 8.0 weeks (2018)
- Online ISSN: 2312-8852 Print ISSN: 1812-9269
Journal is indexed in MEDLINE/PubMed/NLM catalog, EMBASE, SCOPUS, , Index Copernicus, BIOSIS Previews, Thompson Reuters.
Editorial Office of Exp Oncol
Postal address: 45 Vasylkivska Street, Кyiv 03022, Ukraine
Phone: +38 (044) 259-0167
Fax: +38 (044) 258-1656
E-mail: email@example.com; firstname.lastname@example.org